Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-18

Clinical Trial Update: Salmon Peptide Fraction: Safety and Cardiometabolic Health [NA]

View source ↗

Summary

This clinical trial update summarizes the completed study evaluating the safety and cardiometabolic health effects of a salmon peptide fraction in individuals w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salmon peptide fraction

Snippet

Sponsor: Laval University | Conditions: Metabolic Syndrome | NA | Status: COMPLETED